Currently, available weight loss mainly therapeutics works by appetite suppression, increasing body metabolism and interfering with the digestion and absorption patterns.
This report contains market size and forecasts of Weight Loss Therapeutics in Global, including the following market information:
Global Weight Loss Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Weight Loss Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Appetite Suppression Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Weight Loss Therapeutics include Abbott, Sanofi, Novo Nordisk, Arena Pharmaceuticals, Orexigen Therapeutics, Johnson & Johnson, Pfizer, Novartis AG and Biocon, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Weight Loss Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Weight Loss Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Weight Loss Therapeutics Market Segment Percentages, by Type, 2021 (%)
Appetite Suppression
Increasing Body Metabolism
Interfering with the Digestion Absorption Patterns
Global Weight Loss Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Weight Loss Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Specialized Clinics
Retail Pharmacies
Mail Order Pharmacies
Others
Global Weight Loss Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Weight Loss Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Weight Loss Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Weight Loss Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Sanofi
Novo Nordisk
Arena Pharmaceuticals
Orexigen Therapeutics
Johnson & Johnson
Pfizer
Novartis AG
Biocon
VIVUS
Eli Lilly
Amgen
Zafgen
Roche
Eisai